| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/28/2002 | WO2001032702B1 Molecular structure of rhd negative locus |
| 03/28/2002 | WO2001029240A3 Regeneration |
| 03/28/2002 | WO2001009183A3 Polymorphisms in the human mdr-1 gene and applications thereof |
| 03/28/2002 | WO2000063241A9 Methods and compositions for modulating an immune response |
| 03/28/2002 | WO2000047231A9 Novel antisense inhibition of rad51 |
| 03/28/2002 | US20020038469 Delayed progression to aids by a missense allele of the ccr2 gene |
| 03/28/2002 | US20020038017 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 03/28/2002 | US20020038003 Novel antibody recognizing a small subset of human hematopoietic cells |
| 03/28/2002 | US20020038002 To suppress immune system for therapy of symptoms associated with immune disorders such as allergies, transplanted tissue rejection and autoimmune diabetes, rheumatoid arthritis and multiple sclerosis |
| 03/28/2002 | US20020037934 By administering compound that neutralizes the effect of secreted TNF-alpha, such as etanercept or inflixamab |
| 03/28/2002 | US20020037879 Monoclonal antibodies; veterinary medicine |
| 03/28/2002 | US20020037868 Diagnosis using antibodies |
| 03/28/2002 | US20020037852 Anticarcinogenic agents |
| 03/28/2002 | US20020037851 Codes with nucleic acids; antiinflammatory agents |
| 03/28/2002 | US20020037850 Genetic engineering; binding to antibodies |
| 03/28/2002 | US20020037840 Fusion protein |
| 03/28/2002 | US20020037582 Potential effector for the grb7 family of signalling proteins |
| 03/28/2002 | US20020037572 Novel mammalian secreted group III phospholipase A2 |
| 03/28/2002 | US20020037570 Alpha 1,2-fucosyltransferase |
| 03/28/2002 | US20020037558 Generating genetically engineered antibodies from prokaryotes; provide prokaryote, transform, culture cells, recover genetically engineered antibodies |
| 03/28/2002 | US20020037556 Heliothis virescens ultraspiracle (USP) protein |
| 03/28/2002 | US20020037549 ABC transport polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | US20020037539 Detecting expression of mammalian chemokine receptor; obtain cell sample, detect antibody binding, bound antibody indicates presence of receptor |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020037523 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of nervous system, autoimmune, inflammation, glomerulonephritis and osteoporosis disorders |
| 03/28/2002 | US20020037522 Protein; for use in the prevention of antibiotic resistance in cancer therapy |
| 03/28/2002 | US20020037518 Polypeptide for use in the diagnosis, prevention and treatment of cell proliferation and inflammation defects |
| 03/28/2002 | US20020037515 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
| 03/28/2002 | US20020037494 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
| 03/28/2002 | US20020037341 Food containing active strains for inhibiting infection and treating gastritis, gastric and duodenal ulcers |
| 03/28/2002 | US20020037326 Peptides for inhibiting retroviruses |
| 03/28/2002 | US20020037293 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/28/2002 | US20020037289 Combined methods and compositions for tumor vasculature targeting and tumor treatment |
| 03/28/2002 | US20020037288 As therapeutic agents for T cell tumors or B cell tumors (excluding myeloma) |
| 03/28/2002 | US20020037287 For diagnosis and therapy of myeloma and ovarian cancer |
| 03/28/2002 | US20020037285 For diseases such as rheumatoid arthritis, atherosclerosis, granulomatous diseases and multiple sclerosis |
| 03/28/2002 | US20020037250 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 03/28/2002 | DE10135996A1 Identifying metastatic tumor cells and screening for antitumor agents, comprises hybridization to specific cDNA sequences |
| 03/28/2002 | DE10045592A1 Ein Antikörper-TNF-TNF Inhibitor Fusionsprotein (TNF-Selektokin) als zielspezifisches Prozytokin zur Tumortherapie An antibody-TNF TNF inhibitor fusion protein (TNF-Selektokin) as target-specific Prozytokin for tumor therapy |
| 03/28/2002 | DE10043437A1 Verwendung von trifunktionellen bispezifischen und trispezifischen Antikörpern zur Behandlung von malignem Aszites Using trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites |
| 03/28/2002 | CA2632702A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/28/2002 | CA2423181A1 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | CA2423127A1 Immunogen comprising ligand bound hiv envelope protein |
| 03/28/2002 | CA2423104A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | CA2423090A1 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | CA2423058A1 Polypeptide having phospholipase a2 activity |
| 03/28/2002 | CA2422911A1 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | CA2422740A1 G-protein coupled receptor hfrbn63 |
| 03/28/2002 | CA2422631A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | CA2422568A1 Prognostic indicator |
| 03/28/2002 | CA2422549A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/28/2002 | CA2422541A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/28/2002 | CA2422215A1 B7-like molecules and uses thereof |
| 03/28/2002 | CA2421576A1 Human polynucleotides and polypeptides encoded thereby |
| 03/28/2002 | CA2421056A1 A polypeptide for use as a diagnostic marker for the presence of colon tumours |
| 03/28/2002 | CA2420862A1 Protein phosphatases |
| 03/28/2002 | CA2420160A1 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 03/27/2002 | EP1191101A2 Polypeptides and nucleic acids encoding the same |
| 03/27/2002 | EP1191099A1 Novel polypeptide and dna thereof |
| 03/27/2002 | EP1191096A1 Novel protein and dna thereof |
| 03/27/2002 | EP1191036A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 03/27/2002 | EP1191035A2 Three members of the cytokin-receptor class II family |
| 03/27/2002 | EP1190259A1 Diagnostic assay for human matrix gla-protein and its use as a biomarker |
| 03/27/2002 | EP1190257A1 Early detection of flaviviruses using the ns1 glycoprotein |
| 03/27/2002 | EP1190251A2 Detection of ryanodine receptor antibodies |
| 03/27/2002 | EP1190101A1 Compositions and methods for preventing transepithelial transmission of hiv |
| 03/27/2002 | EP1190074A1 Recombinant anti-cd40 antibody and uses thereof |
| 03/27/2002 | EP1190072A2 22012, a novel human carboxypeptidase |
| 03/27/2002 | EP1190071A2 17867, a novel human aminopeptidase |
| 03/27/2002 | EP1190070A1 Cyclic amp phosphodiesterase isoforms and methods of use |
| 03/27/2002 | EP1190065A2 Atp binding cassette transporter protein abc1 polypeptides |
| 03/27/2002 | EP1190063A1 Nucleic and proteinic acids corresponding to human gene abc1 |
| 03/27/2002 | EP1190061A1 Streptavidin expressed gene fusions and methods of use thereof |
| 03/27/2002 | EP1190058A2 Human genes and gene expression products i |
| 03/27/2002 | EP1190057A1 Cloning and expression of a novel 5-ht4 receptor |
| 03/27/2002 | EP1190056A1 Human cytokine receptor |
| 03/27/2002 | EP1190055A2 Human endogenous retrovirus in breast cancer |
| 03/27/2002 | EP1190053A2 Mammalian calcium channels and related probes, cell lines and methods |
| 03/27/2002 | EP1190052A1 16405 receptor, a g-protein coupled receptor |
| 03/27/2002 | EP1190051A2 Human transport proteins |
| 03/27/2002 | EP1190050A2 Human transcriptional regulator proteins |
| 03/27/2002 | EP1190048A2 Novel candida albicans genes and proteins coded by said genes |
| 03/27/2002 | EP1190043A1 Glycoprotein vi and uses thereof |
| 03/27/2002 | EP1190042A2 Methods for manipulating the avian genome |
| 03/27/2002 | EP1189947A1 Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines |
| 03/27/2002 | EP1189946A1 ANTI-$g(a) v?$g(b)3? RECOMBINANT HUMAN ANTIBODIES, NUCLEIC ACIDS ENCODING SAME AND METHODS OF USE |
| 03/27/2002 | EP1189945A1 Antibodies and peptides for detection of plasmodium vivax |
| 03/27/2002 | EP1189937A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
| 03/27/2002 | EP1189934A2 Oligomeric chaperone proteins |
| 03/27/2002 | EP1189931A2 Peptide compounds that bind her2 |
| 03/27/2002 | EP1189917A1 48 human secreted proteins |
| 03/27/2002 | EP1189663A2 Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders |
| 03/27/2002 | EP1189641A2 HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 03/27/2002 | EP1189634A1 Treating prostate cancer with anti-erbb2 antibodies |
| 03/27/2002 | EP1189631A1 Neurodegenerative disorder related gene |
| 03/27/2002 | EP1189630A1 A method of prophylaxis and treatment and agents useful for same |
| 03/27/2002 | EP1189627A1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
| 03/27/2002 | EP1105426A4 Monoclonal antibody inhibitor of gm-csf, il-3, il-5 and other cytokines, and uses thereof |
| 03/27/2002 | EP1007534A4 Bh3 interacting domain death agonist |
| 03/27/2002 | EP0831906B1 Treatment of t cell mediated autoimmune disorders |